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REVIEW
Musculoskeletal manifestations of diabetes mellitus
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Rheumatic complaints are common in patients with
diabetes. Maintaining good glycaemic control by
exercise, diet, and medication improves or prevents the
development of rheumatic conditions.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diabetes mellitus is a chronic metabolic con-dition characterised by persistent hypergly-caemia with resultant morbidity and mor-
tality related primarily to its associated
microvascular and macrovascular complications.
It is common, with recent estimates showing that
7.5% of Australians over 25 have diabetes, of
which 50% of cases are undiagnosed.1 Most of
these patients (85%) have type 2 diabetes
mellitus. Type 1 generally starts in the young as an
autoimmune mediated disease of pancreatic dys-
function, and requires lifelong parenteral insulin
supplementation. Type 2 generally occurs in
people over 40 and is characterised by insulin
resistance.
Physical activity is an attractive treatment for
patients with diabetes given its low cost, non-
pharmacological nature and additional aerobic
and cardiovascular benefits.
Exercise is considered to be one of the three
cornerstones of optimal diabetes treatment, along
with diet and pharmacotherapy.2 It is important
to obtain and maintain optimal glycaemic con-
trol, as poor glycaemic control is associated with
increased prevalence of diabetic complications.3 A
recent meta-analysis has shown that exercise
training in patients with type 2 diabetes mellitus
reduces HbA1C by an amount that should
decrease the risk of diabetic complications. This
was not associated with an appreciably greater
change in body mass in the intervention group
compared with the control group,4 suggesting
that exercise training in patients with type 2
diabetes is valuable in its own right rather than
being just an avenue to weight loss. Physical
activity is therefore an attractive treatment for
patients with diabetes given its low cost, non-
pharmacological nature, and additional aerobic
and cardiovascular benefits.
This review will discuss some of the musculo-
skeletal manifestations of diabetes mellitus. Table
1 shows the prevalence of these conditions in
patients with and without diabetes. Sports physi-
cians and patients with diabetes should be aware
of these manifestations, so that optimal physio-
therapy programmes can be devised that do not
exacerbate existing complaints and encourage
continuing physical activity in this group.
FROZEN SHOULDER
The most disabling of the common musculo-
skeletal problems is adhesive capsulitis, which is
also known as frozen shoulder, shoulder peri-
arthritis, or obliterative bursitis. It is characterised
by progressive, painful restriction of shoulder
movement, especially external rotation and abduc-
tion.5 The thickened joint capsule is closely applied
and adherent to the humeral head, resulting in
considerable reduction in the volume of the gleno-
humeral joint (fig 1). The exact origins of adhesive
capsulitis are not known, although it has been
associated with several other conditions, including
shoulder trauma, cerebral conditions, cardiac con-
ditions, and respiratory conditions. The natural
history of the disease is characterised by three dis-
tinct phases: painful, adhesive, and resolution
phases.5 Adhesive capsulitis appears at a younger
age in patients with diabetes and is usually less
painful,6 although it responds less well to treat-
ment and lasts longer.7 The estimated prevalence is
11–30% in diabetic patients and 2–10% in non-
diabetics.8–11 Adhesive capsulitis is associated with
the duration of diabetes and age.10 11
Diabetic patients with frozen shoulder are
more likely to have other diabetic complications
such as limited joint mobility than diabetics
without a frozen shoulder, although this may be
explained by age.10 11
Most cases of adhesive capsulitis will resolve
over time, but, in the interim, management
consists of adequate analgesia and intra-articular
corticosteroid injections in the painful early
stages if required. Corticosteroid injections may
increase blood sugar levels in diabetics over the
24–48 hour period after the injection, and
Table 1 Prevalence of musculoskeletal disorders in patients with or without diabetes
Musculoskeletal disorder With diabetes Without diabetes
Adhesive capsulitis (frozen shoulder)5–8 11–30% 2–10%
Limited joint mobility9–11 8–50% 0–26%
Dupuytren’s contracture12–15 20–63% 13%
Carpal tunnel syndrome16 17 11–16% 125/100000*
Flexor tenosynovitis18 11% <1%
Diffuse idiopathic skeletal hyperostosis10 15 13–49% 1.6–13%
*Incidence estimate over 5 years.
See end of article for
authors’ affiliations







Accepted 15 August 2002
. . . . . . . . . . . . . . . . . . . . . . .
30
www.bjsportmed.com
 on 28 August 2008 bjsm.bmj.comDownloaded from 
therefore blood sugar monitoring and contingency plans for
elevated blood sugar levels should be considered.Distension or
manipulation under anaesthesia are occasionally considered.
An appropriately graded, regular physiotherapy programme
should be maintained, after the painful phase, throughout the
course of the condition.
HAND SYNDROMES
There is increased incidence of hand abnormalities in patients
with type 1 and type 2 diabetes compared with the general
population. The association between the hand abnormality
and the duration of diabetes but not age or sex is a consistent
finding.12
Limited joint mobility
Limited joint mobility is also known as diabetic cheiroartho-
pathy (after the Greek word “cheiros” for hand). It is charac-
terised by thick, tight, waxy skin mainly on the dorsal aspect
of the hands, with flexion deformities of the metacar-
pophalangeal and interphalangeal joints (increased resistance
to passive extension of the joints). Limited joint mobility can
be shown clinically by the inability of the two palms to come
completely together, with the wrists maximally flexed,
forming the prayer sign (fig 2). In the early stages, paraesthe-
sias and slight pain develop. The symptoms increase very
slowly, and greater pain, aggravated by movement of the
hands, may supervene. Biopsy specimens of involved skin
Figure 4 Hands of patient with reflex sympathetic dystrophy.
Figure 5 Hands of patient with reflex sympathetic dystrophy.
Figure 1 Shoulder arthrogram showing a contracted and adherent
joint capsule in adhesive capsulitis.
Figure 2 Limited joint mobility shown by the inability to press the
two palms completely together, with the wrists maximally flexed,
forming the prayer sign.
Figure 3 Dupuytren’s contracture of the hand.
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show pronounced thickening of periarticular rather than
articular collagen, which may be due to non-enzymatic glyco-
sylation of collagen.13
This condition is most commonly seen in type 1 diabetics,
with a prevalence of 8–50%,6 12 compared with 0–26% in
controls,14 with differences in prevalence estimates possibly
related to differences in the definitions used and perhaps dif-
ferences in glycaemic control.15
Limited joint mobility is more prevalent in patients with
diabetic neuropathy than in those without.16 17 Limited joint
mobility and Dupuytren’s contracture are commonly found in
the same patient.12 17 18 Treatment consists of optimising
glycaemic control and an individualised hand therapy
programme if a patient’s symptoms warrant it.
Dupuytren’s contracture
Dupuytren’s contracture is the palmar or digital thickening,
tethering, or contracture of the hands (fig 3). In patients with
diabetes, the ring and middle finger are more commonly
affected, compared with the fifth finger in patients without
diabetes.19 The prevalence of Dupuytren’s contracture in
diabetic patients ranges from 20 to 63%,16 19 20 compared with
13% in the general population.21 Among patients with
Dupuytren’s contracture, 13–39% have diabetes.19 22 The
contractures are generally milder in diabetics than in patients
with Dupuytren’s contracture who do not have diabetes, and
the prevalence increases with advancing age.23 Treatment con-
sists of optimising glycaemic control, physiotherapy, and hand
exercises if required, and surgery only if function is severely
affected. The contractures are usually mild, however, and
rarely require surgery.6
Carpal tunnel syndrome
Carpal tunnel syndrome (CTS) is a disorder characterised by
paraesthesia over the median nerve cutaneous distribution of
the thumb, index, middle, and lateral half of the ring fingers,
which is often worse at night. The symptomsmay be caused by
compression of the median nerve within the carpal tunnel,
diabetic neuropathy, or a combination of both.24 CTS is
common in patients with diabetes, with an estimated
prevalence of 11–16%,25 26 compared with an incidence of
about 125 per 100 000 population over a five year period.27
About 5–8% of patients with CTS have diabetes.28 CTS is more
common in women than in men. Associations between carpal
tunnel syndrome and age and the duration of diabetes have
been suggested.24 Treatment of CTS consists of the use of sim-
ple analgesics, splints, and possibly local steroid injections for
the milder cases of compressive CTS. Surgery is indicated in
those patients who fail the above conservative measures.
Flexor tenosynovitis
Flexor tenosynovitis (trigger finger or stenosing tenovaginitis)
is caused by fibrous tissue proliferation in the tendon sheath
leading to limitation of the normal movement of the tendon.
The prevalence of flexor tenosynovitis is estimated at 11% in
diabetic patients, compared with <1% in non-diabetics.29
There is also an increased incidence in people with impaired
glucose tolerance.30 Flexor tenosynovitis is associated with the
duration of diabetes but not age.29 A corticosteroid injection
into the symptomatic flexor tendon sheath is often curative.
Figure 6 Radiograph (lateral view) of the thoracic spine showing
flowing osteophytes in diffuse idiopathic skeletal hyperostosis.
Figure 7 Radiograph (anterior view) of the lumbar spine in diffuse
idiopathic skeletal hyperostosis.
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Reflex sympathetic dystrophy
Reflex sympathetic dystrophy is also known as algodystrophy,
Sudeck’s atrophy, and chronic regional pain syndrome type 1. It
is characterised by localised or diffuse pain, usually with associ-
ated swelling, trophic changes, and vasomotor disturbances,31
with impaired mobility of the affected region (figs 4 and 5).
There have been difficulties with the definitions of reflex
sympathetic dystrophy, and the cause, pathogenesis, and natu-
ral history are unclear. The condition may occur spontaneously,
or after minimal trauma—following surgery or a fracture. Con-
current medical conditions may predispose to reflex sympa-
thetic dystrophy, including diabetes mellitus, hyperthyroidism,
hyperparathyroidism, and type IV hyperlipidaemia.32 A variety
of treatments have been used with anecdotal success, including
analgesics, physiotherapy, intravenous bisphosphonates, calci-
tonin, oral corticosteroids, and sympathetic ganglion blocks.32
The outcome is usually good, although some patients develop
chronic pain and contractures.
DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS
Diffuse idiopathic skeletal hyperostosis, also known as
ankylosing hyperostosis or Forestier’s disease, is characterised
by new bone formation, particularly in the thoracolumbar
spine (figs 6 and 7). New bone appears to “flow” from one ver-
tebra to the next, and is more prominent on the right side of
the thoracic vertebra.33 Ossification of ligaments and tendons
elsewhere may occur, such as the skull, pelvis, heels, or
elbows15 34 (fig 8). A proposed mechanism of causation is the
prolonged and high levels of insulin or insulin-like growth fac-
tors occurring in diabetic patients, stimulating new bone
Figure 8 Bilateral calcified Archilles tendons in a patient with
diabetes.
Figure 9 Joint destruction such as is seen in Charcot’s disease.
Figure 10 Joint destruction such as is seen in Charcot’s disease.
Figure 11 Bilateral painless ulcers in a patient with diabetic
peripheral neuropathy.
Figure 12 The nail through the sole of this slipper (see arrow) worn
by a patient with diabetic peripheral neuropathy, was only noticed
at the end of the day when the slipper was romoved.
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growth, and may explain the higher prevalence in type 1 com-
pared with type 2 diabetes (ratio 3:1).20 There may be
associated pain in one third of patients who have hyperostosis
of the heels or elbows. Patients with hyperostosis of the spine
may have associated mild stiffness on arising in the morning,
and 16% of affected persons may develop dysphagia.14 In most
cases affected persons have normal mobility of the spine and
may be asymptomatic, with the diagnosis of the condition an
incidental radiographic finding.15 Estimated prevalence is
13–49% in diabetic patients6 and 1.6–13% in non-diabetics.20
Among patients with diffuse idiopathic skeletal hyperostosis,
12–80% have diabetes or impaired glucose tolerance. The high
prevalence of abnormal glucose tolerance tests in patients with
diffuse idiopathic skeletal hyperostosis is partly a result of an
association with obesity, with 83% of patients being male and
30% obese.14 Obesity and diabetes seem to have independent
contributions to the development of the condition.14
Rates of hyperostosis increase with age in both the normal
and diabetic populations, although the age related increase in
incidence begins earlier in diabetics.6 Management consists of
education, diabetic control, and physiotherapy.
NEUROPATHIC (CHARCOT’S) JOINTS
Charcot’s disease, or joints, is a result of diabetic peripheral
neuropathy. A reduction in the normal afferent protective
neural impulses, and therefore loss of protection from trauma
to the joint leads to progressive, painless joint destruction (figs
9 and 10). Charcot’s joints are typically seen in patients over
the age of 50 who have had diabetes for many years and have
existing neuropathic complications (figs 11 and 12). The joints
most commonly affected are weight-bearing joints such as the
foot, ankles, and knees; joints such as the hand and wrist are
rarely affected.35 Initial warmth and erythema mimic osteo-
myelitis or septic arthritis, but the absence of fever, elevated
white cell count, and elevated erythrocyte sedimentation rate
helps to differentiate the latter two conditions. Management
consists of optimising glycaemic control and regular foot care
and review, particularly in those with grossly impaired sensa-
tion. The use of orthotics and crutches can relieve pressure on
the affected joints during ambulation.35 Occasionally surgery
may be required if complicated fractures develop.
DIABETIC AMYOTROPHY
Diabetic amyotrophy is a disabling illness that is distinct from
other forms of diabetic neuropathy. It is characterised by
muscle weakness and wasting, and by diffuse, proximal lower
limb muscle pain, and asymmetrical loss of tendon jerks. The
shoulder girdle may be affected, but less commonly (fig 13). It
typically occurs in older men with type 2 diabetes, and is often
associated with weight loss, sometimes as much as 40% of
premorbid body mass. The exact cause and incidence of
diabetic amyotrophy is uncertain. It is a diagnosis of
exclusion: sinister causes must be sought and excluded
because of the clinical picture of weight loss and new neuro-
logical signs. Management consists of stabilising glycaemic
control and use of physiotherapy. Most cases improve, but the
improvement is gradual and often incomplete.36
CONCLUSION
The complications of diabetes mellitus are numerous and
include involvement of the musculoskeletal system. Several
rheumatic conditions are more prevalent or caused by the long
term metabolic consequences of diabetes mellitus. When the
control of diabetes is poor, higher levels of diabetic complica-
tions result.3 Poor glycaemic control can lead to worsening of
certain rheumatic conditions. Pharmacotherapy, diet, and a
regular, sensible physiotherapy programme should be the cor-
nerstone of diabetes management. It is our recommendation
that all patients with diabetes have an appropriate exercise
programme, overseen by their medical practitioner, as an inte-
gral part of their diabetes management in order to reduce the
frequency and severity of complications.
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